Viewing Study NCT00811902


Ignite Creation Date: 2025-12-25 @ 4:02 AM
Ignite Modification Date: 2026-02-01 @ 5:31 AM
Study NCT ID: NCT00811902
Status: COMPLETED
Last Update Posted: 2016-02-26
First Post: 2008-12-18
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy, Safety, and Tolerability of Nerispirdine in Patients With Multiple Sclerosis
Sponsor: Sanofi
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Sclerosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Multiple sclerosis View